Novartis post hoc analysis shows high-dose Enerzair® Breezhaler® reduces asthma exacerbations versus medium-dose, complementing key pivotal IRIDIUM study findings.
September 7, 2020: "Novartis announced that...
September 04, 2020: "The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
The FDA issued...
September 03, 2020: "The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
The FDA’s COVID-19-related...
Sept. 3, 2020: "Sanofi and GSK started the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine.
The vaccine candidate, developed in partnership by...
September 01, 2020: "Roche announced that it will launch a SARS-CoV-2 Rapid Antigen Test, in late September, for markets accepting the CE Mark.
Roche...
"Toxicokinetics is basically the study of "how and what happens to a substance in the body"
What is Toxicokinetics?
Toxicokinetics (TK) is characterised as the generation...
SEPTEMBER 1, 2020: BMS announced that the U.S.FDA has approved Onureg® (azacitidine 300 mg tablets, CC-486) for the continued treatment of adult patients with acute myeloid...
September 1, 2020: "Medtronic, the global leader in medical technology announced it has received U.S. FDA approval of its MiniMed™ 770G hybrid closed loop...
September 01, 2020: "The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
The FDA has,...
September 1, 2020: "The Food and Drug Administration approved azacitidine tablets (ONUREG®, Celgene Corporation) for continued treatment of patients with acute myeloid leukemia who...